Literature DB >> 31426022

Establishment of a Beals syndrome patient-derived human induced pluripotent stem cell line HELPi001-A.

Hao Liu1, Yatping Tsui2, Jiaxian Wang3, Chen Su4, Rui Zheng5, Yongfeng Shao6, Buqing Ni7.   

Abstract

The human induced pluripotent stem cell line HELPi001-A was derived from peripheral blood mononuclear cells (PBMC) of a 35-year-old female Beals syndrome patient carrying a heterozygous FBN2c.728 T > C mutation. HELPi001-A were positive for pluripotent stem cell markers, had a normal karyotype and the ability to differentiate into cells representing all three germ layers. The patient not only demonstrated typical characteristics of Beals syndrome such as joint contractures and crumpled ears, but also demonstrated aortic dissection. HELPi001-A could serve as a platform for exploring the pathogenesis of cardiovascular and connective tissue disorders related to FBN2 mutation.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31426022     DOI: 10.1016/j.scr.2019.101535

Source DB:  PubMed          Journal:  Stem Cell Res        ISSN: 1873-5061            Impact factor:   2.020


  1 in total

1.  Identification of Novel FBN2 Variants in a Cohort of Congenital Contractural Arachnodactyly.

Authors:  Liying Sun; Yingzhao Huang; Sen Zhao; Wenyao Zhong; Jile Shi; Yang Guo; Junhui Zhao; Ge Xiong; Yuehan Yin; Zefu Chen; Nan Zhang; Zongxuan Zhao; Qingyang Li; Dan Chen; Yuchen Niu; Xiaoxin Li; Guixing Qiu; Zhihong Wu; Terry Jianguo Zhang; Wen Tian; Nan Wu
Journal:  Front Genet       Date:  2022-03-10       Impact factor: 4.599

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.